Low-cost electrochemical sensor using waste coffee ground-derived electrodes modified with metallo-porphyrins for rapid screening of acrylamide in drinking water. The patented flexographic printing technology enables multi-electrode sensor chips that combine differential pulse voltammetry with artificial neural network pattern recognition for accurate acrylamide concentration detection.
This solution offers a rapid, low-cost electrochemical screening tool for detecting acrylamide in drinking water. Acrylamide is a potentially harmful contaminant that can form during high-temperature cooking processes and enter water supplies, posing health concerns that require reliable monitoring. The sensor leverages waste coffee grounds (WCG) as a sustainable electrode material combined with metallo-porphyrin chemistry to achieve direct electrochemical detection of acrylamide at potentials where dissolved oxygen does not interfere. This approach provides water utilities, food manufacturers, and environmental testing laboratories with an accessible alert system for acrylamide presence in water samples.
Key features:
The technology is currently at an early-to-mid stage of development. Preliminary laboratory results have demonstrated that amides can interact directly with metallo-porphyrins under specific potentials, establishing the scientific basis for the approach. The research team is now seeking funding for a research assistant to advance the project over a six-month period. The next phase involves printing the multi-electrode sensor chip, completing the matrix of voltammetric measurements, and developing the ANN-based pattern recognition algorithm for concentration determination. Upon successful completion of this validation phase, the technology will be positioned for further development toward field deployment and commercialization.
Swansea University is a comprehensive public research university with dual campuses along Swansea Bay and a partnership-driven, applied research culture. Purpose-built facilities on the Bay Campus co-locate engineering research with company spaces and pilot-scale testbeds, accelerating product development and contract R&D. The Medical School works closely with NHS partners, with an adjacent hospital supporting clinical translation and real‑world evaluation. Research activity is backed by competitive national funding through UK Research and Innovation and Innovate UK, alongside NHS collaborations and Welsh Government support. A dedicated technology transfer office manages IP, licensing and spinout formation, with access to on‑campus collaboration and incubation space.